Weiss G, Werner-Felmayer G, Werner E R, Grünewald K, Wachter H, Hentze M W
Department of Internal Medicine, University of Innsbruck, Austria.
J Exp Med. 1994 Sep 1;180(3):969-76. doi: 10.1084/jem.180.3.969.
Recently, it was reported that nitric oxide (NO) directly controls intracellular iron metabolism by activating iron regulatory protein (IRP), a cytoplasmic protein that regulates ferritin translation. To determine whether intracellular iron levels themselves affect NO synthase (NOS), we studied the effect of iron on cytokine-inducible NOS activity and mRNA expression in the murine macrophage cell line J774A.1. We show here that NOS activity is decreased by about 50% in homogenates obtained from cells treated with interferon gamma plus lipopolysaccharide (IFN-gamma/LPS) in the presence of 50 microM ferric iron [Fe(3+)] as compared with extracts from cells treated with IFN-gamma/LPS alone. Conversely, addition of the iron chelator desferrioxamine (100 microM) at the time of stimulation with IFN-gamma/LPS increases NOS activity up to 2.5-fold in J774 cells. These effects of changing the cellular iron state cannot be attributed to a general alteration of the IFN-gamma/LPS signal, since IFN-gamma/LPS-mediated major histocompatibility complex class II antigen expression is unaffected. Furthermore, neither was the intracellular availability of the NOS cofactor tetrahydrobiopterin altered by treatment with Fe(3+) or desferrioxamine, nor do these compounds interfere with the activity of the hemoprotein NOS in vitro. We demonstrate that the mRNA levels for NOS are profoundly increased by treatment with desferrioxamine and reduced by Fe(3+). The half-life of NOS mRNA appeared not to be significantly altered by administration of ferric ion, and NOS mRNA stability was only slightly prolonged by desferrioxamine treatment. Nuclear run-off experiments demonstrate that nuclear transcription of cytokine-inducible NOS mRNA is strongly increased by desferrioxamine whereas it is decreased by Fe(3+). Thus, this transcriptional response appears to account quantitatively for the changes in enzyme activity. Our results suggest the existence of a regulatory loop between iron metabolism and the NO/NOS pathway.
最近有报道称,一氧化氮(NO)可通过激活铁调节蛋白(IRP)直接控制细胞内铁代谢,IRP是一种调节铁蛋白翻译的细胞质蛋白。为了确定细胞内铁水平本身是否影响一氧化氮合酶(NOS),我们研究了铁对小鼠巨噬细胞系J774A.1中细胞因子诱导的NOS活性和mRNA表达的影响。我们在此表明,与单独用γ干扰素/脂多糖(IFN-γ/LPS)处理的细胞提取物相比,在存在50微摩尔三价铁[Fe(3+)]的情况下,用γ干扰素加脂多糖(IFN-γ/LPS)处理的细胞匀浆中,NOS活性降低了约50%。相反,在J774细胞中用IFN-γ/LPS刺激时添加铁螯合剂去铁胺(100微摩尔)可使NOS活性增加至2.5倍。改变细胞铁状态的这些效应不能归因于IFN-γ/LPS信号的普遍改变,因为IFN-γ/LPS介导的主要组织相容性复合体II类抗原表达不受影响。此外,用Fe(3+)或去铁胺处理既未改变NOS辅因子四氢生物蝶呤的细胞内可用性,这些化合物在体外也不干扰血红蛋白NOS的活性。我们证明,用去铁胺处理可使NOS的mRNA水平显著增加,而Fe(3+)则使其降低。三价铁的给药似乎未显著改变NOS mRNA的半衰期,而去铁胺处理仅略微延长了NOS mRNA的稳定性。核转录实验表明,去铁胺可强烈增加细胞因子诱导的NOS mRNA的核转录,而Fe(3+)则使其降低。因此,这种转录反应似乎在数量上解释了酶活性的变化。我们的结果表明铁代谢与NO/NOS途径之间存在调节环路。